This document is an excerpt from the EUR-Lex website
Document C:2001:286:TOC
Official Journal of the European Communities, C 286, 12 October 2001
Official Journal of the European Communities, C 286, 12 October 2001
Official Journal of the European Communities, C 286, 12 October 2001
Official Journal of the European Communities | ISSN
0378-6986 C 286 Volume 44 12 October 2001 |
English edition | Information and Notices | ||
Notice No | Contents | Page | |
I Information | |||
Council | |||
2001/C 286/01 | List of appointments made by the Council — July, August and September 2001 (social field) | 1 | |
Commission | |||
2001/C 286/02 | Euro exchange rates | 2 | |
2001/C 286/03 | Non-opposition to a notified concentration (Case COMP/M.2513 — RWE/Kärntner Energie Holding) (1) | 3 | |
2001/C 286/04 | Note for guidance on minimising the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products (EMEA/410/01 Rev. 1 — May 2001) adopted by the Committee for Proprietary Medicinal Products (CPMP) and by the Committee for Veterinary Medicinal Products (CVMP) — July 2001 | 4 | |
2001/C 286/05 | Position paper on risk assessment of the use of starting materials of ruminant origin in veterinary medicinal products intended for use in ruminant species (EMEA/CVMP/121/01 — February 2001) adopted by the Committee for Veterinary Medicinal Products (CVMP) — July 2001 | 10 | |
2001/C 286/06 | Position paper on the assessment of the risk of transmission of animal spongiform encephalopathy agents by master seed materials used in the production of veterinary vaccines (EMEA/CVMP/019/01 — February 2001) adopted by the Committee for Veterinary Medicinal Products (CVMP) — July 2001 | 12 | |
EN | (1) Text with EEA relevance |